PMP News

For acute pain, prescriber shall not issue an initial prescription for an opioid drug in a quantity exceeding seven (7) day supply.

Prescription shall be for the lowest effective dose of immediate-release opioid drug and must state “acute pain” on the face of the prescription. 63 O.S. §2-309I(A).

Oklahoma Senate Bill 848: Requires doctors and chronic-pain patients to enter into a treatment agreement. Requires a patient be staged through a limited initial prescription, a limited second prescription, and then be formally advised that continued opioid use can result in addiction. Prescriptions are required to notate on the prescription if the prescription is for acute or chronic pain.

The Oklahoma PMP has reinstated three (3) Clinical Alerts featured on the PMP system. These Clinical Alerts are being provided only as a tool to assist you in indentifying potential at risk patients. They are NOT intended to suggest a course of medical treatment or to replace the judgement of qualified medical and pharmacy professionals. These Clinical Alerts are NOT sent as an indication that the patient or practitioner has done anything wrong. Active alerts are NOT grounds for investigations against practitioners.

Clinical Alerts will be generated for the following:

As of November 2015, the Oklahoma Legislature enacted HB 1948 mandating that all practitioners who write controlled prescriptions for opioids, benzodiazepines or Soma check the PMP. There are exceptions for Hospice, long term nursing facilities and end-of-life care. State licensing boards are responsible for enforcing this provision and setting policy. Please contact your licensing board for questions and guidance. Other changes in the bill include providing access to the PMP by the Office of the Chief Medical Examiner, the Board of Nursing, and Board of Examiners in Optometry.